Organization
Saint-Louis Hospital
1 clinical trial
4 abstracts
Abstract
Efficacy and safety of ciltacabtagene autoleucel ± lenalidomide maintenance in newly diagnosed multiple myeloma with suboptimal response to frontline autologous stem cell transplant: CARTITUDE-2 cohort D.Org: Saint-Louis Hospital, APHP, University Paris Cité, Paris and Saint Cloud, France,
Clinical trial
Beyond the Syndromic Approach in Critical Care: Identifying Biomarker-driven Subphenotypes of Circulatory ShockStatus: Active (not recruiting), Estimated PCD: 2025-07-01
Abstract
Impact of histology on the efficacy and safety of pembrolizumab (pembro) monotherapy for advanced urothelial carcinoma (UC) in the phase 3 KEYNOTE-045 and KEYNOTE-361 trials.Org: Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy, Cliniques Universitaires Saint-Luc (UCLouvain), Brussels, Belgium, Aichi Medical University, Nagakute, Japan, Hospital General Universitario Gregorio Marañón, Madrid, Spain, Tokyo Medical and Dental University Hospital, Tokyo, Japan,
Abstract
ACROOSTEOLYSIS IS ASSOCIATED WITH VASCULAR COMPLICATIONS OF SYSTEMIC SCLEROSISOrg: Club Rhumatismes et Inflammation, Rheumatology and Clinical Immunology, Biomedical Engineering, Vascular diseases, University Medical Center, Groningen, Netherlands, Internal Medicine Residency, AP-HP at Saint-Louis Hospital, Cochin Hospital,
Abstract
ANALYSIS OF SKIN EXTRACELLULAR MATRIX ORGANISATION IN SYSTEMIC SCLEROSISOrg: INSERM U697, Service d'anapathologie, Saint-Louis Hospital, Service de médecine interne et Inflammation-Immunopathology-Biotherapy Department (DMU i3), Saint Antoine Hospital,